These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2569956)

  • 21. The use of zolpidem in the treatment of progressive supranuclear palsy.
    Cotter C; Armytage T; Crimmins D
    J Clin Neurosci; 2010 Mar; 17(3):385-6. PubMed ID: 20071178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive supranuclear palsy: clinical features and response to treatment in 16 patients.
    Jackson JA; Jankovic J; Ford J
    Ann Neurol; 1983 Mar; 13(3):273-8. PubMed ID: 6847139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressive supranuclear palsy.
    Pourfar M; Vonsattel JP
    Sci Aging Knowledge Environ; 2004 Jul; 2004(30):dn1. PubMed ID: 15282366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of progressive supranuclear palsy improved with tandospirone citrate].
    Iijima M; Terashi H; Iwata M
    Rinsho Shinkeigaku; 2001; 41(2-3):150-3. PubMed ID: 11481861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progressive supranuclear palsy].
    Goetz CG
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S25-9. PubMed ID: 12773885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A
    Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progressive supranuclear palsy (PSP)].
    Nishimiya J; Yuasa T
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):45-8. PubMed ID: 10434587
    [No Abstract]   [Full Text] [Related]  

  • 28. Progressive supranuclear palsy.
    Duvoisin RC; Golbe LI; Lepore FE
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):547-54. PubMed ID: 3315157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
    Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
    Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tremor in progressive supranuclear palsy.
    Fujioka S; Algom AA; Murray ME; Sanchez-Contreras MY; Tacik P; Tsuboi Y; Van Gerpen JA; Uitti RJ; Rademakers R; Ross OA; Wszolek ZK; Dickson DW
    Parkinsonism Relat Disord; 2016 Jun; 27():93-7. PubMed ID: 27039056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Improvement of ophthalmoplegia by 5-hydroxytryptophan in two cases of progressive supranuclear palsy].
    Yukitake M; Takashima Y; Kurohara K; Matsui M; Kuroda Y
    Rinsho Shinkeigaku; 1996 Jul; 36(7):906-8. PubMed ID: 8952364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical effectiveness of tandospirone citrate (5-HT1A agonist) on patients with progressive supranuclear palsy].
    Fujino Y; Nakajima M; Tsuboi Y; Baba Y; Yamada T
    Rinsho Shinkeigaku; 2002 Jan; 42(1):42-4. PubMed ID: 12355852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive supranuclear palsy: a brief personalized history.
    Daroff RB
    Yale J Biol Med; 1987; 60(2):119-22. PubMed ID: 3577208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy.
    Moccia M; Picillo M; Erro R; Allocca R; Barone P; Vitale C
    J Neurol Sci; 2015 Mar; 350(1-2):103-4. PubMed ID: 25697711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ballooned neurons in progressive supranuclear palsy are usually due to concurrent argyrophilic grain disease.
    Togo T; Dickson DW
    Acta Neuropathol; 2002 Jul; 104(1):53-6. PubMed ID: 12070664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dopaminergic drug-induced jaw-opening dystonia in a patient with progressive supranuclear palsy].
    Tano O; Kaneko K; Kikuchi A; Hasegawa T; Takeda A; Aoki M
    Rinsho Shinkeigaku; 2013; 53(4):308-11. PubMed ID: 23603547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pramipexole in progressive supranuclear palsy.
    Weiner WJ; Minagar A; Shulman LM
    Neurology; 1999 Mar; 52(4):873-4. PubMed ID: 10078747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological hypersexuality induced by dopamine replacement therapy in a patient with progressive supranuclear palsy.
    Kim YY; Park HY; Kim JM; Kim KW
    J Neuropsychiatry Clin Neurosci; 2008; 20(4):496-7. PubMed ID: 19196941
    [No Abstract]   [Full Text] [Related]  

  • 39. Progressive supranuclear palsy: clinical features, pathophysiology and management.
    Rajput A; Rajput AH
    Drugs Aging; 2001; 18(12):913-25. PubMed ID: 11888346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A trial of progressive supranuclear palsy with carbamazepine].
    Klimek A; Wojciechowska J; Niewinowska-Rupf K; Kobielski A
    Neurol Neurochir Pol; 1998; 32(4):959-67. PubMed ID: 9864724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.